5-Bromosalicylic acid → 5-Bromo-N-[4,5-bis(furan-2-yl)oxazol-2-yl]-2-hydroxybenzamide
Reaction equation
[Br:1][C:2]1[CH:10]=[C:6]([C:7]([OH:9])=O)[C:5]([OH:11])=[CH:4][CH:3]=1.[NH2:12][C:13]1[O:14][C:15]([C:23]2[O:24][CH:25]=[CH:26][CH:27]=2)=[C:16]([C:18]2[O:19][CH:20]=[CH:21][CH:22]=2)[N:17]=1>>[Br:1][C:2]1[CH:3]=[CH:4][C:5]([OH:11])=[C:6]([CH:10]=1)[C:7]([NH:12][C:13]1[O:14][C:15]([C:23]2[O:24][CH:25]=[CH:26][CH:27]=2)=[C:16]([C:18]2[O:19][CH:20]=[CH:21][CH:22]=2)[N:17]=1)=[O:9]Participants
3
Procedure
Using 5-bromosalicylic acid and 2-amino-4,5-bis(furan-2-yl)oxazole as the raw materials, the same operation as the Example 16 gave the title compound.
Sources & evidence
- ORD record
- ord-91ba6830b3924ed09631946753d80667
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07700655B2
Reaction notes
Loading…